<code id='A82F796147'></code><style id='A82F796147'></style>
    • <acronym id='A82F796147'></acronym>
      <center id='A82F796147'><center id='A82F796147'><tfoot id='A82F796147'></tfoot></center><abbr id='A82F796147'><dir id='A82F796147'><tfoot id='A82F796147'></tfoot><noframes id='A82F796147'>

    • <optgroup id='A82F796147'><strike id='A82F796147'><sup id='A82F796147'></sup></strike><code id='A82F796147'></code></optgroup>
        1. <b id='A82F796147'><label id='A82F796147'><select id='A82F796147'><dt id='A82F796147'><span id='A82F796147'></span></dt></select></label></b><u id='A82F796147'></u>
          <i id='A82F796147'><strike id='A82F796147'><tt id='A82F796147'><pre id='A82F796147'></pre></tt></strike></i>

          knowledge

          knowledge

          author:comprehensive    Page View:6512

          Is there a cure for allergies? Has the FDA become too flexible? And which drugs make you muscular?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recorded live from from the STAT Breakthrough Summit East in New York City, we discuss some event highlights, including words from CRISPR pioneer Feng Zhang and Regeneron Pharmaceuticals head scientist George Yancopoulos. We also discuss the latest news in the life sciences, including a twist in the GLP-1 story, the cost of gene therapy, and, of course, pie.

          advertisement

          For more on what we cover, here’s our full Summit coverage; here’s more on Medicare and GLP-1s; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          focus

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          It's time to retire 'poor historian' from clinicians' vocabularies
          It's time to retire 'poor historian' from clinicians' vocabularies

          AdobeShouldwepitythe“poorhistorians”—theindividualsorfamilymemberswhocan’tgiveaclearaccountingofthei

          read more
          Continuity nursing helped my family in our darkest PICU moments
          Continuity nursing helped my family in our darkest PICU moments

          EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

          read more

          Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

          John-ArneRøttingenistheheadoftheWellcomeTrust,oneoftheworld’stopprivatefundersofbiomedicalresearch.I